Cannabinoids for autism behavior are increasingly discussed by families seeking help for irritability, aggression, sleep, anxiety, and daily functioning. This review finds a limited but clinically relevant signal for selected outcomes, especially with high-CBD, low-THC formulations, while many standardized results remain mixed or null. The safest interpretation is careful, physician-guided, symptom-specific, and honest about what the evidence does not prove.
Cannabis Medicines Show Modest Promise for Nerve Pain, But Evidence Remains Inconclusive
CBM treatments may improve pain scores, but study limitations such as small sample sizes and study durations, high placebo response rates, and trial unblinding because of the psychoactive effects of cannabinoids all hinder data interpretation and the extrapolation to chronic pain conditions.
Cannabis Medicines Show Modest Promise for Nerve Pain, But Evidence Remains Inconclusive
CBM treatments may improve pain scores, but study limitations such as small sample sizes and study durations, high placebo response rates, and trial unblinding because of the psychoactive effects of cannabinoids all hinder data interpretation and the extrapolation to chronic pain conditions.
CBD and Colon Cancer: A Promising Hypothesis Built on Preclinical Ground
By influencing the serotonergic system, CBD may confer both protective and potentially deleterious effects during CRC development.
Do Video Games and Cannabis Use Go Hand in Hand? A New Review Maps the Evidence
Evidence suggests that a relationship does exist, as the majority of studies did find a positive relationship between VG and cannabis use, although several studies also found no significant relationship, and a few even found a negative relationship.
Cannabis Hyperemesis Syndrome in Youth: A Narrative Review Highlights Clinical Gaps and Public Health Urgency
While definitive causation has not been established, emerging evidence suggests that chronic use of high-potency cannabis may be associated with a heightened risk of developing CHS. Younger individuals are also disproportionately affected compared to middle-aged or older adults.
CBD in Childhood Epilepsy: What the Evidence Actually Shows
Several randomized controlled trials in children and adults with epilepsy syndromes such as Lennox-Gastaut syndrome and Dravet syndrome have demonstrated meaningful reduction in seizures following the administration of cannabidiol.
Cannabis for Nerve Pain: Mixed Evidence From 22 Trials, No Clear Winners Yet
Collectively, CBM treatments may improve pain scores, but study limitations such as small sample sizes and study durations, high placebo response rates, and trial unblinding because of the psychoactive effects of cannabinoids all hinder data interpretation and the extrapolation to chronic pain conditions.
What the Evidence Really Says About CBD for Children With Epilepsy
Several randomized controlled trials in children and adults with epilepsy syndromes such as Lennox-Gastaut syndrome and Dravet syndrome have demonstrated meaningful reduction in seizures following the administration of cannabidiol.
Gum Disease and Diabetes Share Epigenetic Fingerprints—Could CBD or Metformin Help?
Whilst there are numerous studies that have evaluated the anti-inflammatory effect of CBD in periodontitis, the mechanisms by which it modulates epigenetic changes, considered at least partially responsible for the pathological degeneration in DM, to our knowledge, have not yet been elucidated.